Home › Novartis Boost Seen in Fast Cancer Drug Review as Protection Ends: Health
 

Keywords :   


Novartis Boost Seen in Fast Cancer Drug Review as Protection Ends: Health

2013-05-06 03:24:00| Biotech - Topix.net

Just as Novartis AG 's best-selling medicines are losing patent protection, the company is poised to get a revenue boost from a U.S. program designed to speed life- saving therapies to patients with few treatment options.

Tags: health review fast protection

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.07Atlantic Tropical Weather Outlook
05.07Eastern North Pacific Tropical Weather Outlook
04.07Hurricane Beryl Graphics
04.07Hurricane Beryl Forecast Discussion Number 25
04.07Hurricane Beryl Public Advisory Number 25
04.07Summary for Hurricane Beryl (AT2/AL022024)
04.07Hurricane Beryl Wind Speed Probabilities Number 25
04.07Hurricane Beryl Forecast Advisory Number 25
More »